Not recruiting
Chronic obstructive pulmonary disease
Not recruitingStudy Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients
Registered drugNo placebo
Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients
Registered drugNo placebo
- Disease:Chronic obstructive pulmonary disease
- Substances:Aclidinium BromideFluticasone Furoate+13
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:Aclidinium Bromide
